| Dr Catherine D Quinn, MD | |
|
3075 Health Center Dr Ste 102, San Diego, CA 92123-2773 | |
| (858) 637-7888 | |
| Not Available |
| Full Name | Dr Catherine D Quinn |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Hematology & Oncology |
| Location | 3075 Health Center Dr Ste 102, San Diego, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427403641 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | A162757 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Catherine D Quinn, MD 3075 Health Center Dr Ste 102, San Diego, CA 92123-2773 Ph: (858) 637-7888 | Dr Catherine D Quinn, MD 3075 Health Center Dr Ste 102, San Diego, CA 92123-2773 Ph: (858) 637-7888 |
News Archive
While African American men are more likely to die from cardiovascular disease, they paradoxically have fewer cases of coronary obstruction than clinically similar white men, according to a new national study led by a Medical College of Wisconsin researcher.
Since the emergence of the coronavirus disease (COVID-19) pandemic, little is known about the risks of COVID-19 to pregnant women. Now, a new study reveals that pregnant women with COVID-19 are less likely to experience symptoms of fever and myalgia than non-pregnant women of reproductive age, but maybe at a heightened risk of being admitted to intensive care.
The presence of collagen in the tumor microenvironment, essentially where the tumor lives, can be either good or bad according to Constance Brinckerhoff, PhD who led the Dartmouth team's reporting of "The BRAFV600E inhibitor, PLX4032, increases type 1 collagen synthesis in melanoma cells," in Matrix Biology Journal.
A new method of stimulating the renewal of living stem cells in tooth pulp using an Alzheimer's drug has been discovered by a team of researchers at King's College London.
Nanotechnology may open a new door on the treatment of liver cancer, according to a team of Penn State College of Medicine researchers. They used molecular-sized bubbles filled with chemotherapy drugs to prevent cell growth and initiate cell death in test tubes and mice.
› Verified 1 days ago
Dr. Ramin Motarjemi, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 200 W Arbor Dr, San Diego, CA 92103 Phone: 858-249-2500 Fax: 858-657-8069 | |
Dr. Shweta Warner, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4647 Zion Ave, San Diego, CA 92120 Phone: 619-221-6258 Fax: 619-221-6012 | |
Dr. Matthew James Roosevelt, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4647 Zion Ave, Department Of Hospital Medicine, San Diego, CA 92120 Phone: 619-952-5091 | |
Dr. Daniel Joseph Desantis, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: Naval Medical Ctr, 34800 Bob Wilson Dr., San Diego, CA 92134 Phone: 619-532-7935 | |
Kris Kumar, Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 200 W Arbor Dr, San Diego, CA 92103 Phone: 800-926-8273 Fax: 888-539-8781 | |
Jedidiah Daniel Bell, Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 200 W Arbor Dr, San Diego, CA 92103 Phone: 619-471-0434 | |
Dr. Umber Dube, MD PHD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 8899 University Center Lane, Suite 350 Mc 0975, San Diego, CA 92122 Phone: 858-657-1675 |